Nikolai Petrovsky, PhD

Research Director and Professor of Medicine, Vaxine Pty Ltd

Nikolai Petrovsky is Research Director of Vaxine, an Adelaide-based biotechnology company focused on vaccine development and Professor of Medicine at Flinders University. He is a clinical endocrinologist and has a PhD in immunology. His work in vaccines and artificial intelligence has been awarded over 50 million dollars in grants from the US National Institutes of Health. He has authored over 200 peer-reviewed research papers and is an inventor on multiple vaccine patents. He developed SpikoGen®, a vaccine against COVID-19 that in October 2021 received emergency use authorization in the Middle east, making it the first recombinant spike protein vaccine against Covid-19 in the world to achieve regulatory approval and the first novel approved human vaccine developed in Australia since the Q fever vaccine 40 years ago.

Got a question for Nikolai Petrovsky, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content

Total: 1

Online Event

Cell and Gene Therapy 2023

This inaugural event will showcase recent advances in the development of cell and gene therapies and the opportunities they provide for the treatment of disease and injury. Focus will be given to cancer immunotherapies and vaccines, stem cells, vector technologies and examples of genetic modification to treat a range of conditions.